ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
ICU MEDICAL INC/DE
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$161.24−1.75 (-1.07%)
Close on Oct 19, 2026
- Market cap
- $4.04B
- P/E (TTM)
- 134.4
- Dividend yield
- –
Share price
+$42.78 (+36.11%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
ICU MEDICAL INC/DE saw revenue fall 9.0% to $2.16B over the twelve months to Jun 30, 2026. Operating income rose 3.8% to $72.06M, moving the operating margin from 2.9% to 3.3%. Free cash flow was $152.83M, up 152.5% from a year earlier.
Revenue
$2.16B
-9.0% vs. a year earlier
Operating income
$72.06M
+3.8% vs. a year earlier
Free cash flow
$152.83M
+152.5% vs. a year earlier
EPS, diluted
$1.20
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $4.04B
- P/E ratio
- 134.4
- Price to sales
- 1.87
- Price to book
- 1.88
- Dividend yield
- –
- Free cash flow yield
- 3.78%
Fundamentals
- Revenue
- $2.16B
- Net income
- $30.09M
- EPS, diluted
- $1.20
- Free cash flow
- $152.83M
- Book value per share
- $85.92
- Diluted shares
- 25M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$2.16B-9.0% YoY
Gross profit
$845.15M-0.6% YoY
Operating income
$72.06M+3.8% YoY
Net income
$30.09M
EPS, diluted
$1.20
Free cash flow
$152.83M+152.5% YoY
Reported periodTrailing twelve months